These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15085916)

  • 1. Construct validity of the RAND-12 and Health Utilities Index Mark 2 and 3 in type 2 diabetes.
    Maddigan SL; Feeny DH; Johnson JA;
    Qual Life Res; 2004 Mar; 13(2):435-48. PubMed ID: 15085916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes.
    Maddigan SL; Feeny DH; Johnson JA;
    Med Decis Making; 2003; 23(6):489-501. PubMed ID: 14672109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life deficits associated with varying degrees of disease severity in type 2 diabetes.
    Maddigan SL; Majumdar SR; Toth EL; Feeny DH; Johnson JA;
    Health Qual Life Outcomes; 2003 Dec; 1():78. PubMed ID: 14675484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial.
    Raisch DW; Feeney P; Goff DC; Narayan KM; O'Connor PJ; Zhang P; Hire DG; Sullivan MD
    Cardiovasc Diabetol; 2012 Jul; 11():35. PubMed ID: 22515638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the RAND-12 and SF-12 summary scores in type 2 diabetes.
    Johnson JA; Maddigan SL
    Qual Life Res; 2004 Mar; 13(2):449-56. PubMed ID: 15085917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence on the construct validity of the Health Utilities Index Mark 2 and Mark 3 in patients with chronic kidney disease.
    Davison SN; Jhangri GS; Feeny DH
    Qual Life Res; 2008 Aug; 17(6):933-42. PubMed ID: 18543076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness and construct validity of the health utilities index in patients with dementia.
    Kavirajan H; Hays RD; Vassar S; Vickrey BG
    Med Care; 2009 Jun; 47(6):651-61. PubMed ID: 19433998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal construct validity of the Health Utilities Indices Mark 2 and Mark 3 in hip fracture.
    Jones CA; Pohar SL; Feeny DH; Eng K
    Qual Life Res; 2014 Apr; 23(3):805-13. PubMed ID: 24081869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease.
    Neumann PJ; Sandberg EA; Araki SS; Kuntz KM; Feeny D; Weinstein MC
    Med Decis Making; 2000; 20(4):413-22. PubMed ID: 11059474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Utilities Index mark 3 demonstrated construct validity in a population-based sample with type 2 diabetes.
    Maddigan SL; Feeny DH; Majumdar SR; Farris KB; Johnson JA
    J Clin Epidemiol; 2006 May; 59(5):472-7. PubMed ID: 16632135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United States.
    Luo N; Johnson JA; Shaw JW; Coons SJ
    Med Care; 2009 Jan; 47(1):53-60. PubMed ID: 19106731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutual concurrent validity of the child health questionnaire and the health utilities index: an exploratory analysis using survivors of childhood cancer.
    Nixon Speechley K; Maunsell E; Desmeules M; Schanzer D; Landgraf JM; Feeny DH; Barrera ME
    Int J Cancer Suppl; 1999; 12():95-105. PubMed ID: 10679879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construct validity for the Health Utilities Index in a sleep center.
    Welch KC; Scharf SM
    Sleep Breath; 2007 Dec; 11(4):295-303. PubMed ID: 17457630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cohort study found the RAND-12 and Health Utilities Index Mark 3 demonstrated construct validity in high-risk primary care patients.
    Feeny D; Farris K; Côté I; Johnson JA; Tsuyuki RT; Eng K
    J Clin Epidemiol; 2005 Feb; 58(2):138-41. PubMed ID: 15680746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misinterpretation with norm-based scoring of health status in adults with type 1 diabetes.
    Supina AL; Feeny DH; Carroll LJ; Johnson JA
    Health Qual Life Outcomes; 2006 Mar; 4():15. PubMed ID: 16542446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing directly measured standard gamble scores to HUI2 and HUI3 utility scores: group- and individual-level comparisons.
    Feeny D; Furlong W; Saigal S; Sun J
    Soc Sci Med; 2004 Feb; 58(4):799-809. PubMed ID: 14672594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon's indices.
    Bas Janssen MF; Birnie E; Bonsel GJ
    Qual Life Res; 2007 Jun; 16(5):895-904. PubMed ID: 17294285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer.
    Bowker SL; Pohar SL; Johnson JA
    Health Qual Life Outcomes; 2006 Mar; 4():17. PubMed ID: 16553957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the psychometric properties of generic utility measures in multiple sclerosis.
    Kuspinar A; Mayo NE
    Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A parent-child dyad approach to the assessment of health status and health-related quality of life in children with asthma.
    Ungar WJ; Boydell K; Dell S; Feldman BM; Marshall D; Willan A; Wright JG
    Pharmacoeconomics; 2012 Aug; 30(8):697-712. PubMed ID: 22788260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.